NorthboundBio: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
NorthboundBio
Largest movements
- Cash +€135,502
up €135,502 (+140.9%), from €96,149 to €231,651
mainly Net result for the year (+€141,107) and Tax, wage and social debts (+€23,468)
- Receivables within one year -€22,767
down €22,767 (-98.2%), from €23,191 to €424
- Financial fixed assets +€22,728
up €22,728 (+181.8%), from €12,501 to €35,229
- Deferred charges and accrued income +€19,029
up €19,029 (+7355.2%), from €259 to €19,288
- Reserves +€141,107
up €141,107 (+171.2%), from €82,413 to €223,519
- Tax, wage and social debts +€23,468
up €23,468 (+70.7%), from €33,200 to €56,668
- Other debts -€11,295
down €11,295 (-83.9%), from €13,470 to €2,175
- Gross operating margin +€75,076
up €75,076 (+70.5%), from €106,512 to €181,588
- Taxes +€19,338
up €19,338 (+91.5%), from €21,133 to €40,471
- Depreciation -€2,816
down €2,816 (-100.0%), from €2,816 to €0
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €132,100 | €286,592 | +€154,493 | +117.0% |
| Fixed assets | 21/28 | €12,501 | €35,229 | +€22,728 | +181.8% |
| Financial fixed assets | 28 | €12,501 | €35,229 | +€22,728 | +181.8% |
| Current assets | 29/58 | €119,599 | €251,363 | +€131,764 | +110.2% |
| Amounts receivable within one year | 40/41 | €23,191 | €424 | -€22,767 | -98.2% |
| Trade receivables | 40 | €23,191 | €424 | -€22,767 | -98.2% |
| Cash at bank and in hand | 54/58 | €96,149 | €231,651 | +€135,502 | +140.9% |
| Deferred charges and accrued income | 490/1 | €259 | €19,288 | +€19,029 | +7355.2% |
| Total equity and liabilities | 10/49 | €132,100 | €286,592 | +€154,493 | +117.0% |
| Equity | 10/15 | €85,413 | €226,519 | +€141,107 | +165.2% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €82,413 | €223,519 | +€141,107 | +171.2% |
| Distributable reserves | 133 | €82,413 | €223,519 | +€141,107 | +171.2% |
| Amounts payable | 17/49 | €46,687 | €60,073 | +€13,386 | +28.7% |
| Amounts payable within one year | 42/48 | €46,687 | €60,073 | +€13,386 | +28.7% |
| Trade debts | 44 | €17 | €1,229 | +€1,213 | +7166.2% |
| Suppliers | 440/4 | €17 | €1,229 | +€1,213 | +7166.2% |
| Taxes, remuneration and social security | 45 | €33,200 | €56,668 | +€23,468 | +70.7% |
| Taxes | 450/3 | €33,200 | €56,668 | +€23,468 | +70.7% |
| Other amounts payable | 47/48 | €13,470 | €2,175 | -€11,295 | -83.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,816 | €0 | -€2,816 | -100.0% |
| Other operating charges | 640/8 | €106 | €112 | +€6 | +5.9% |
| Gross operating margin | 9900 | €106,512 | €181,588 | +€75,076 | +70.5% |
| Operating profit (loss) | 9901 | €103,591 | €181,476 | +€77,885 | +75.2% |
| Financial income | 75/76B | - | €230 | +€230 | |
| Recurring financial income | 75 | - | €230 | +€230 | |
| Financial charges | 65/66B | €45 | €128 | +€84 | +187.2% |
| Recurring financial charges | 65 | €45 | €128 | +€84 | +187.2% |
| Profit (loss) for the period before taxes | 9903 | €103,546 | €181,578 | +€78,032 | +75.4% |
| Income taxes | 67/77 | €21,133 | €40,471 | +€19,338 | +91.5% |
| Profit (loss) for the period | 9904 | €82,413 | €141,107 | +€58,694 | +71.2% |
| Profit (loss) for the period to be appropriated | 9905 | €82,413 | €141,107 | +€58,694 | +71.2% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.